SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000905718-18-000999
Filing Date
2018-12-27
Accepted
2018-12-27 16:20:08
Documents
2
Group Members
ABINGWORTH BIOVENTURES VII, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D soleno_13ddec212018.htm SC 13D 72344
2 JOINT FILING AGREEMENT soleno_13ddec212018ex99.htm EX-1 9852
  Complete submission text file 0000905718-18-000999.txt   83810
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

IRS No.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13D

Mailing Address 1235 RADIO ROAD SUITE 110 REDWOOD CITY CA 94065
Business Address 1235 RADIO ROAD SUITE 110 REDWOOD CITY CA 94065 650-213-8444
SOLENO THERAPEUTICS INC (Subject) CIK: 0001484565 (see all company filings)

IRS No.: 770523891 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88637 | Film No.: 181254908
SIC: 3845 Electromedical & Electrotherapeutic Apparatus